Document Type
Patent
Publication Date
October 2015
Patent Number
9150604
CPC
C07H 19/23(20130101), A61K 31/70(20130101), A61K 31/7042(20130101), A61K 31/7052(20130101)
Abstract
The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat esophogeal adenocarcinoma by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.
Application Number
13/908,821
Recommended Citation
Cheng, Jin Q., "Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds" (2015). USF Patents. 61.
https://digitalcommons.usf.edu/usf_patents/61
Assignees
University of South Florida
Filing Date
06/03/2013
